Not Yet Recruiting Bozitinib Combined With Chemotherapy as Radical Treatment for Stage IIA-IIIC MET-Altered Non-Small Cell Lung Cancer NCT07153770 Conditions MET Activating Mutation, MET Exon 14 Mutation, NSCLC Locations Not specified View Trial Details
Completed Study of Crizotinib for ROS1 and MET Activated Lung Cancer NCT04084717 Conditions Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more Locations Princess Margaret Cancer Centre — Toronto, Ontario, Canada View Trial Details
